LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 13

Search options

  1. Article ; Online: Emerging roles of RNA-binding proteins in fatty liver disease.

    Adesanya, Oluwafolajimi / Das, Diptatanu / Kalsotra, Auinash

    Wiley interdisciplinary reviews. RNA

    2024  Volume 15, Issue 2, Page(s) e1840

    Abstract: A rampant and urgent global health issue of the 21st century is the emergence and progression of fatty liver disease (FLD), including alcoholic fatty liver disease and the more heterogenous metabolism-associated (or non-alcoholic) fatty liver disease ( ... ...

    Abstract A rampant and urgent global health issue of the 21st century is the emergence and progression of fatty liver disease (FLD), including alcoholic fatty liver disease and the more heterogenous metabolism-associated (or non-alcoholic) fatty liver disease (MAFLD/NAFLD) phenotypes. These conditions manifest as disease spectra, progressing from benign hepatic steatosis to symptomatic steatohepatitis, cirrhosis, and, ultimately, hepatocellular carcinoma. With numerous intricately regulated molecular pathways implicated in its pathophysiology, recent data have emphasized the critical roles of RNA-binding proteins (RBPs) in the onset and development of FLD. They regulate gene transcription and post-transcriptional processes, including pre-mRNA splicing, capping, and polyadenylation, as well as mature mRNA transport, stability, and translation. RBP dysfunction at every point along the mRNA life cycle has been associated with altered lipid metabolism and cellular stress response, resulting in hepatic inflammation and fibrosis. Here, we discuss the current understanding of the role of RBPs in the post-transcriptional processes associated with FLD and highlight the possible and emerging therapeutic strategies leveraging RBP function for FLD treatment. This article is categorized under: RNA in Disease and Development > RNA in Disease.
    MeSH term(s) Humans ; Non-alcoholic Fatty Liver Disease/genetics ; RNA-Binding Proteins/genetics ; Phenotype ; RNA ; RNA, Messenger
    Chemical Substances RNA-Binding Proteins ; RNA (63231-63-0) ; RNA, Messenger
    Language English
    Publishing date 2024-04-08
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2634714-3
    ISSN 1757-7012 ; 1757-7004
    ISSN (online) 1757-7012
    ISSN 1757-7004
    DOI 10.1002/wrna.1840
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Government preparedness and response towards COVID-19 outbreak in Nigeria: A retrospective analysis of the last 6 months.

    Adesanya, Oluwafolajimi A

    Journal of global health

    2020  Volume 10, Issue 2, Page(s) 20382

    MeSH term(s) COVID-19/epidemiology ; COVID-19/prevention & control ; Civil Defense/statistics & numerical data ; Disease Outbreaks/statistics & numerical data ; Humans ; Nigeria/epidemiology ; Pandemics/prevention & control ; Pandemics/statistics & numerical data ; Retrospective Studies
    Keywords covid19
    Language English
    Publishing date 2020-08-19
    Publishing country Scotland
    Document type Journal Article ; Review
    ZDB-ID 2741629-X
    ISSN 2047-2986 ; 2047-2978
    ISSN (online) 2047-2986
    ISSN 2047-2978
    DOI 10.7189/jogh.10.020382
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Improving the Management and Treatment of Diabetic Foot Infection: Challenges and Research Opportunities.

    Turzańska, Kaja / Adesanya, Oluwafolajimi / Rajagopal, Ashwene / Pryce, Mary T / Fitzgerald Hughes, Deirdre

    International journal of molecular sciences

    2023  Volume 24, Issue 4

    Abstract: Diabetic foot infection (DFI) management requires complex multidisciplinary care pathways with off-loading, debridement and targeted antibiotic treatment central to positive clinical outcomes. Local administration of topical treatments and advanced wound ...

    Abstract Diabetic foot infection (DFI) management requires complex multidisciplinary care pathways with off-loading, debridement and targeted antibiotic treatment central to positive clinical outcomes. Local administration of topical treatments and advanced wound dressings are often used for more superficial infections, and in combination with systemic antibiotics for more advanced infections. In practice, the choice of such topical approaches, whether alone or as adjuncts, is rarely evidence-based, and there does not appear to be a single market leader. There are several reasons for this, including a lack of clear evidence-based guidelines on their efficacy and a paucity of robust clinical trials. Nonetheless, with a growing number of people living with diabetes, preventing the progression of chronic foot infections to amputation is critical. Topical agents may increasingly play a role, especially as they have potential to limit the use of systemic antibiotics in an environment of increasing antibiotic resistance. While a number of advanced dressings are currently marketed for DFI, here we review the literature describing promising future-focused approaches for topical treatment of DFI that may overcome some of the current hurdles. Specifically, we focus on antibiotic-impregnated biomaterials, novel antimicrobial peptides and photodynamic therapy.
    MeSH term(s) Humans ; Diabetic Foot/drug therapy ; Anti-Bacterial Agents/therapeutic use ; Communicable Diseases/drug therapy ; Bandages ; Diabetes Mellitus/drug therapy
    Chemical Substances Anti-Bacterial Agents
    Language English
    Publishing date 2023-02-15
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2019364-6
    ISSN 1422-0067 ; 1422-0067 ; 1661-6596
    ISSN (online) 1422-0067
    ISSN 1422-0067 ; 1661-6596
    DOI 10.3390/ijms24043913
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Thoracic endometriosis syndrome: Cutting the gordian knot - A case report and review of the literature.

    Adesanya, Oluwafolajimi A / Kolawole, Oludayo E

    International journal of surgery case reports

    2019  Volume 66, Page(s) 68–71

    Abstract: Introduction: Thoracic Endometriosis Syndrome (TES) is a rare disorder characterized by the presence of functional endometrial tissue in the thoracic cavity, often associated with the visceral or parietal pleura, lung parenchyma or airways. The aim of ... ...

    Abstract Introduction: Thoracic Endometriosis Syndrome (TES) is a rare disorder characterized by the presence of functional endometrial tissue in the thoracic cavity, often associated with the visceral or parietal pleura, lung parenchyma or airways. The aim of this case report is to illustrate the classic manner of presentation of TES and the modalities of therapy employed in a low-resource setting in the South-Western region of Nigeria.
    Case presentation: We report the case of a 37-year old woman who presented with right-sided pleuritic chest pain, cough and dyspnea closely associated with her menstrual cycle. On examination, there were reduced breath sounds and decreased air entry on the right hemithorax as well as dull percussion notes on the right middle and lower lung zones. Chest X-ray revealed signs of right-sided pleural effusion. Working diagnosis of right-sided Catamenial Pneumothorax was made for which she had 3 sessions of chemical pleurodesis which failed to close the air leaks. She eventually has a right-sided posterolateral thoracotomy and was co-managed by the O&G team with monthly Goserelin injections.
    Conclusion: This case illustrates the difficulties physicians in low-resource settings face in the diagnosis and treatment of TES and the importance of a high index of suspicion as well as a multidisciplinary approach in patient care.
    Language English
    Publishing date 2019-11-27
    Publishing country Netherlands
    Document type Case Reports
    ISSN 2210-2612
    ISSN 2210-2612
    DOI 10.1016/j.ijscr.2019.11.032
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Expanded Scope of Bacillus Calmette-Guerin (BCG) Vaccine Applicability in Disease Prophylaxis, Diagnostics, and Immunotherapeutics.

    Adesanya, Oluwafolajimi A / Uche-Orji, Christabel I / Adedeji, Yeshua A / Joshua, John I / Adesola, Adeniyi A / Chukwudike, Chibuike J

    Infectious microbes & diseases

    2020  Volume 2, Issue 4, Page(s) 144–150

    Abstract: Following the discovery of the Bacillus Calmette-Guerin (BCG) vaccine, its efficacy ... ...

    Abstract Following the discovery of the Bacillus Calmette-Guerin (BCG) vaccine, its efficacy against
    Language English
    Publishing date 2020-10-20
    Publishing country United States
    Document type Journal Article ; Review
    ISSN 2641-5917
    ISSN (online) 2641-5917
    DOI 10.1097/IM9.0000000000000040
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Bacillus Calmette-Guerin (BCG): the adroit vaccine.

    Adesanya, Oluwafolajimi A / Uche-Orji, Christabel I / Adedeji, Yeshua A / Joshua, John I / Adesola, Adeniyi A / Chukwudike, Chibuike J

    AIMS microbiology

    2021  Volume 7, Issue 1, Page(s) 96–113

    Abstract: Background: The Bacillus Calmette-Guerin (BCG) vaccine has been in use for 99 years, and is regarded as one of the oldest human vaccines known today. It is recommended primarily due to its effect in preventing the most severe forms of tuberculosis, ... ...

    Abstract Background: The Bacillus Calmette-Guerin (BCG) vaccine has been in use for 99 years, and is regarded as one of the oldest human vaccines known today. It is recommended primarily due to its effect in preventing the most severe forms of tuberculosis, including disseminated tuberculosis and meningeal tuberculosis in children; however, its efficacy in preventing pulmonary tuberculosis and TB reactivation in adults has been questioned. Several studies however have found that asides from its role in tuberculosis prevention, the BCG vaccine also has protective effects against a host of other viral infections in humans, an effect which has been termed: heterologous, non-specific or off-target.
    Objectives: As we approach 100 years since the discovery of the BCG vaccine, we review the evidence of the non-specific protection offered by the vaccine against viral infections, discuss the possible mechanisms of action of these effects, highlight the implications these effects could have on vaccinology and summarize the recent epidemiological correlation between the vaccine and the on-going COVID-19 pandemic.
    Results: Several epidemiological studies have established that BCG does reduce all-cause mortality in infants, and also the time of vaccination influences this effect significantly. This effect has been attributed to the protective effect of the vaccine in preventing unrelated viral infections during the neonatal period. Some of such viral infections that have been investigated include: herpes simplex virus (HSV), human Papilloma virus (HPV), yellow fever virus (YFV), respiratory syncytial virus (RSV) and influenza virus type A (H1N1). These effects are thought to be mediated via induction of innate immune memory as well as heterologous lymphocytic activation. While epidemiological studies have suggested a correlation, the potential protection of the BCG vaccine against COVID-19 transmission and mortality rates is currently unclear. Ongoing clinical trials and further research may shed more light on the subject in the future.
    Conclusion: BCG is a multifaceted vaccine, with many numerous potential applications to vaccination strategies being employed for current and future viral infections. There however is a need for further studies into the immunologic mechanisms behind these non-specific effects, for these potentials to become reality, as we usher in the beginning of the second century since the vaccine's discovery.
    Language English
    Publishing date 2021-02-08
    Publishing country United States
    Document type Journal Article ; Review
    ISSN 2471-1888
    ISSN (online) 2471-1888
    DOI 10.3934/microbiol.2021007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Infectious disease outbreak preparedness and response in Nigeria: history, limitations and recommendations for global health policy and practice.

    Olumade, Testimony J / Adesanya, Oluwafolajimi A / Fred-Akintunwa, Iyanuoluwa J / Babalola, David O / Oguzie, Judith U / Ogunsanya, Olusola A / George, Uwem E / Akin-Ajani, Oluwawapelumi D / Osasona, Damilola G

    AIMS public health

    2020  Volume 7, Issue 4, Page(s) 736–757

    Abstract: Effective disease outbreak response has historically been a challenging accomplishment for the Nigerian health system due to an array of hurdles not unique to Nigeria but also found in other African nations which share its large size and complexity. ... ...

    Abstract Effective disease outbreak response has historically been a challenging accomplishment for the Nigerian health system due to an array of hurdles not unique to Nigeria but also found in other African nations which share its large size and complexity. However, the efficiency of the response mounted against the Ebola Virus Disease (EVD) outbreak of 2014 proved that indeed, though challenging, proactive and effective outbreak response is not impossible. With over 20 public health emergencies and infectious disease outbreaks between 2016 and 2018 alone, Nigeria is one of only five members of the World Health Organization (WHO) African Region to report five or more public health events per annum. There are many lessons that can be drawn from Nigeria's experience in handling outbreaks of infectious diseases. In this review, we discuss the history of emerging and re-emerging infectious disease outbreaks in Nigeria and explore the response strategies mounted towards each. We also highlight the significant successes and note-worthy limitations, which we have then utilized to proffer policy recommendations to strengthen the Nigerian public health emergency response systems.
    Language English
    Publishing date 2020-09-22
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 2777115-5
    ISSN 2327-8994 ; 2327-8994
    ISSN (online) 2327-8994
    ISSN 2327-8994
    DOI 10.3934/publichealth.2020057
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Infectious disease outbreak preparedness and response in Nigeria

    Testimony J Olumade / Oluwafolajimi A Adesanya / Iyanuoluwa J Fred-Akintunwa / David O Babalola / Judith U Oguzie / Olusola A Ogunsanya / Uwem E George / Oluwawapelumi D Akin-Ajani / Damilola G Osasona

    AIMS Public Health, Vol 7, Iss 4, Pp 736-

    history, limitations and recommendations for global health policy and practice

    2020  Volume 757

    Abstract: Effective disease outbreak response has historically been a challenging accomplishment for the Nigerian health system due to an array of hurdles not unique to Nigeria but also found in other African nations which share its large size and complexity. ... ...

    Abstract Effective disease outbreak response has historically been a challenging accomplishment for the Nigerian health system due to an array of hurdles not unique to Nigeria but also found in other African nations which share its large size and complexity. However, the efficiency of the response mounted against the Ebola Virus Disease (EVD) outbreak of 2014 proved that indeed, though challenging, proactive and effective outbreak response is not impossible. With over 20 public health emergencies and infectious disease outbreaks between 2016 and 2018 alone, Nigeria is one of only five members of the World Health Organization (WHO) African Region to report five or more public health events per annum. There are many lessons that can be drawn from Nigeria's experience in handling outbreaks of infectious diseases. In this review, we discuss the history of emerging and re-emerging infectious disease outbreaks in Nigeria and explore the response strategies mounted towards each. We also highlight the significant successes and note-worthy limitations, which we have then utilized to proffer policy recommendations to strengthen the Nigerian public health emergency response systems.
    Keywords infectious diseases ; outbreak preparedness ; outbreak response ; global health policy ; nigeria ; Public aspects of medicine ; RA1-1270
    Subject code 360
    Language English
    Publishing date 2020-12-01T00:00:00Z
    Publisher AIMS Press
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article ; Online: COVID-19 Outbreak in Africa

    Oluwafolajimi Adesanya

    International Journal of Travel Medicine and Global Health, Vol 8, Iss 3, Pp 96-

    Lessons and Insights from the West African Ebola Virus Disease Epidemics

    2020  Volume 99

    Abstract: Over the years, the African continent has had to battle several outbreaks of infectious diseases in different countries. Some of the most deadly were the Ebola virus disease (EVD) outbreaks that occurred in West Africa between 2014 and 2016 affecting ... ...

    Abstract Over the years, the African continent has had to battle several outbreaks of infectious diseases in different countries. Some of the most deadly were the Ebola virus disease (EVD) outbreaks that occurred in West Africa between 2014 and 2016 affecting Guinea, Liberia, and Sierra Leone and, more recently, from 2018 to 2020 in the Democratic Republic of Congo (DRC). In the era of the COVID-19 pandemic, it is important that as a continent, we draw lessons and insights from our past experiences to guide outbreak response strategies being deployed to curb the latest onslaught. The Ebola outbreaks have shown that disease outbreaks should not be seen only as medical emergencies, but as full blown humanitarian crises, because oftentimes, their socio-economic impacts are more devastating than the more obvious cost to life. In this mini-review, we explore the possible humanitarian costs of the COVID-19 pandemic on the African continent by looking through the lens of our past experiences with the EVD outbreaks, highlighting how the current pandemic could significantly affect the African economy, food security, and vulnerable demographics, like children and the sexual and reproductive health and rights of women and girls. We then proffer recommendations that could be instrumental in preventing a double tragedy involving the devastating health consequences of the virus itself and the deadly fallout from its multi-sectoral knock-on effects in African countries.
    Keywords covid-19 ; sars-cov-2 ; ebola virus disease ; coronavirus ; Medicine ; R
    Language English
    Publishing date 2020-08-01T00:00:00Z
    Publisher International Travel Medicine Center of Iran
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  10. Article ; Online: COVID-19 Outbreak in Africa

    Adesanya, Oluwafolajimi Adetoye

    International Journal of Travel Medicine and Global Health

    Lessons and Insights from the West African Ebola Virus Disease Epidemics

    2020  Volume 8, Issue 3, Page(s) 96–99

    Abstract: Over the years, the African continent has had to battle several outbreaks of infectious diseases in different countries. Some of the most deadly were the Ebola virus disease (EVD) outbreaks that occurred in West Africa between 2014 and 2016 affecting ... ...

    Abstract Over the years, the African continent has had to battle several outbreaks of infectious diseases in different countries. Some of the most deadly were the Ebola virus disease (EVD) outbreaks that occurred in West Africa between 2014 and 2016 affecting Guinea, Liberia, and Sierra Leone and, more recently, from 2018 to 2020 in the Democratic Republic of Congo (DRC). In the era of the COVID-19 pandemic, it is important that as a continent, we draw lessons and insights from our past experiences to guide outbreak response strategies being deployed to curb the latest onslaught. The Ebola outbreaks have shown that disease outbreaks should not be seen only as medical emergencies, but as full blown humanitarian crises, because oftentimes, their socio-economic impacts are more devastating than the more obvious cost to life. In this mini-review, we explore the possible humanitarian costs of the COVID-19 pandemic on the African continent by looking through the lens of our past experiences with the EVD outbreaks, highlighting how the current pandemic could significantly affect the African economy, food security, and vulnerable demographics, like children and the sexual and reproductive health and rights of women and girls. We then proffer recommendations that could be instrumental in preventing a double tragedy involving the devastating health consequences of the virus itself and the deadly fallout from its multi-sectoral knock-on effects in African countries. Keywords: COVID-19, SARS-CoV-2, Ebola Virus Disease, Coronavirus.
    Keywords covid19
    Language English
    Publisher Maad Rayan Publishing Company
    Publishing country de
    Document type Article ; Online
    ISSN 2476-5759
    DOI 10.34172/ijtmgh.2020.17
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top